Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 09, 2018 07:30 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals Announces Upcoming Oral Presentation at EASL Annual Meeting

SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), a biotechnology company focused on the development of novel medicines to treat liver disease, today...
April 04, 2018 16:05 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals Announces Top-line Results from Phase 2b POLT-HCV-SVR Clinical Trial

Biopsy-based Proof of Concept in Liver Fibrosis and Cirrhosis Supports Further Evaluation Conference Call and Webcast Presentation at 4:30 p.m. ET Today SAN DIEGO, April 04, 2018 (GLOBE NEWSWIRE)...
March 07, 2018 16:05 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals Reports 2017 Financial Results and Program Updates

SAN DIEGO, March 07, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver...
March 05, 2018 07:30 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts at Upcoming Investor Conferences

SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- At three upcoming investor conferences in March, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) President, Chief Executive Officer and co-founder, Steven J....
February 28, 2018 07:30 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results

SAN DIEGO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that it will report financial results for the fourth quarter and full year ended December 31,...
February 12, 2018 07:30 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals to Host Expert Call on Unmet Need in HCV-SVR Patients

SAN DIEGO, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) will host a conference call and webcast presentation at 12:00 p.m. ET on Tuesday, February 20, with liver...
February 05, 2018 07:30 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts and Strategic Initiatives at Upcoming Investor Events

SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- In a presentation and in scheduled meetings with members of the investment community in New York next week, Conatus Pharmaceuticals Inc. (NASDAQ:CNAT)...
November 07, 2017 07:30 ET | Source: Conatus Pharmaceuticals Inc.

Conatus to Present at Stifel Healthcare Conference

SAN DIEGO, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced its scheduled presentation to provide an overview of the company’s programs and outlook at the...
November 01, 2017 16:05 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals Reports Third Quarter 2017 Financial Results and Program Updates

SAN DIEGO, Nov. 01, 2017 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver...
October 25, 2017 07:30 ET | Source: Conatus Pharmaceuticals Inc.

Conatus Pharmaceuticals to Report Third Quarter 2017 Financial Results

SAN DIEGO, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that it will report financial results for the third quarter ended September 30, 2017,...